Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:835-836 (27 October), doi:10.1136/bmj.39359.614387.80 (published 22 October 2007)
In resource poor settings, a sleeping patient is better than one who needs constant observation
| The first 150 words of the full text of this article appear below. |
Two randomised controlled trials in this week's BMJ assess the effectiveness of different combinations of drugs for tranquillising and sedating people who are violent or agitated as a result of psychiatric disorders.1 2 Both trials were undertaken in developing countries.
The first trial, by Raveendran and colleagues, was carried out in the emergency services of a general psychiatry department in a hospital in South India. It compared the tranquillising and sedative effects of a single intramuscular administration of either olanzapine (10 mg) or a combination of haloperidol (10 mg) plus promethazine (50 mg) in 300 aggressive or agitated patients. The observation period lasted for four hours only and patients were followed up for just two weeks. This contrasts with most randomised controlled trials in psychiatry, which have treatment periods lasting for four to 12 weeks and can have several months of follow-up. The trial is important, however, because it looks at
Chittaranjan Andrade, professor and head of department
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore 560 029, India
andradec@gmail.com
Read all Rapid Responses